Sonya L Heath
Overview
Explore the profile of Sonya L Heath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Happe M, Lynch R, Fichtenbaum C, Heath S, Koletar S, Landovitz R, et al.
JCI Insight
. 2025 Feb;
10(4).
PMID: 39989458
BACKGROUNDHIV-1-specific broadly neutralizing monoclonal antibodies (bNAbs) have emerged as promising interventions with the potential to effectively treat and prevent HIV-1 infections. We conducted a phase I clinical trial evaluating the...
2.
Yarava A, Marshall C, Reichert D, Ye A, Khanal P, Robbins S, et al.
J Clin Transl Sci
. 2024 Dec;
8(1):e200.
PMID: 39655012
Introduction: In response to the COVID-19 pandemic, we rapidly implemented a plasma coordination center, within two months, to support transfusion for two outpatient randomized controlled trials. The center design was...
3.
Erdmann N, Heath S
Adv Exp Med Biol
. 2024 Aug;
1448:269-274.
PMID: 39117820
HIV infection triggers an inflammatory response that manifests as acute retroviral syndrome (ARS) in most individuals infected by HIV. While this syndrome is usually self-limited, primary HIV infection sometimes triggers...
4.
Siddiqui M, Burkholder G, Judd E, Wang Z, Colantonio L, Ghazi L, et al.
Am J Hypertens
. 2024 Jun;
37(10):759-768.
PMID: 38890772
Background: Integrase strand transfer inhibitors (INSTIs) are a commonly used antiretroviral therapy (ART) class in people with human immunodeficiency virus (HIV) and associated with weight gain. We studied the association...
5.
Crowell T, Ritz J, Zheng L, Naqvi A, Cyktor J, Puleo J, et al.
AIDS
. 2024 Mar;
38(8):1141-1152.
PMID: 38489580
Objective: To assess how antiretroviral therapy (ART) initiation during acute or early HIV infection (AEHI) affects the viral reservoir and host immune responses. Design: Single-arm trial of ART initiation during...
6.
Park H, Yin A, Barranta C, Lee J, Caputo C, Sachithanandham J, et al.
JCI Insight
. 2024 Mar;
9(8.
PMID: 38483534
BACKGROUNDCOVID-19 convalescent plasma (CCP) virus-specific antibody levels that translate into recipient posttransfusion antibody levels sufficient to prevent disease progression are not defined.METHODSThis secondary analysis correlated donor and recipient antibody levels...
7.
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions"
Gebo K, Heath S, Fukuta Y, Zhu X, Baksh S, Abraham A, et al.
mBio
. 2023 Dec;
15(1):e0297923.
PMID: 38095433
No abstract available.
8.
Jacobson J, Felber B, Chen H, Pavlakis G, Mullins J, De Rosa S, et al.
AIDS
. 2023 Dec;
38(7):963-973.
PMID: 38051788
Objective: The primary objective of the study was to assess the immunogenicity of an HIV-1 Gag conserved element DNA vaccine (p24CE DNA) in people with HIV (PWH) receiving suppressive antiretroviral...
9.
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial
Habtehyimer F, Zhu X, Redd A, Gebo K, Abraham A, Patel E, et al.
Microbiol Spectr
. 2023 Nov;
12(1):e0328623.
PMID: 38009954
This study examined the role that cytokines may have played in the beneficial outcomes found when outpatient individuals infected with SARS-CoV-2 were transfused with COVID-19 convalescent plasma (CCP) early in...
10.
Gebo K, Heath S, Fukuta Y, Zhu X, Baksh S, Abraham A, et al.
mBio
. 2023 Sep;
14(5):e0061823.
PMID: 37724870
Approximately 20% of individuals infected with SARS-CoV-2 experienced long-term health effects, as defined PCC. However, it is unknown if there are any early biomarkers associated with PCC or whether early...